Nanjing King-friend Bioche (603707.SS) traded flat 0 % during a 24 hours period ending at 11:17 PM Central Europe on Monday 26th. One Nanjing King-friend Bioche stock can currently be bought for about CNY 8.3 on popular exchanges. Current supply of Nanjing King-friend Bioche stocks is 1.6 bn. Nanjing King-friend Bioche has a current market capitalization of CNY 13.2 bn and approximately CNY 85.4 mn worth of Nanjing King-friend Bioche was traded on exchanges in the last 24 hours. Since last month end, Nanjing King-friend Bioche has traded 5.84 % up. Simple moving average of last 200 days is at CNY 7.82. The highest price of past 52 weeks was recorded at CNY 10.46 on 11/14/2025. 52 weeks low was at CNY 6.72 on 06/29/2026.

Here is how related stocks have performed in the past 24 hours:

  • Shandong Weifang Rainbow C (301035.SZ) traded flat 0 % and now trades at CNY 42.57. Shandong Weifang Rainbow C has a market capitalisation of CNY 15.7 bn. Shandong Weifang Rainbow C has a current price to earnings ratio of 15.76.

  • Yunnan Shennong Agricultur (605296.SS) traded flat 0 % and now trades at CNY 29.88. Yunnan Shennong Agricultur has a market capitalisation of CNY 15.7 bn.

  • Chagee (CHA) traded down -0.8 % and now trades at USD 12.41. Current market capitalisation for Chagee is USD 2.4 bn.

  • Cecep Environmental Protec (300140.SZ) traded flat 0 % and now trades at CNY 5.15. Current market capitalisation for Cecep Environmental Protec is CNY 15.8 bn. Cecep Environmental Protec has a current price to earnings ratio of 17.27.

  • An Hui Wenergy (000543.SZ) traded flat 0 % and now trades at CNY 7.14. An Hui Wenergy has a market capitalisation of CNY 15.8 bn. Current price/earnings ratio for An Hui Wenergy is 8.58.

About Nanjing King-friend Bioche

Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is a health care company operating in the pharmaceutical industry of China. The company produces heparin sodium raw materials, enoxaparin sodium, naltptone calcium injections, and other products. They market their products throughout China and their official website is www.nkf-pharma.com . The company is listed on the Shanghai Stock Exchange.